Koble claims that its data-driven Software as a Service (SaaS) tool helps accelerators and incubators streamline their selection process so they can focus on the most promising founders. The company's vision is to price early-stage startup risk and reward. It intends to move from a Software as a Service (SaaS) workflow tool to the startup-investor marketplace. Koble asserts that pre-seed and seed investors lack a quantitative approach in the early stage of recognising promising startups. Koble argues that its approach is different; it claims that its algorithms are built to mimic the decision processes (both analytical and intuitive) that humans go through when analysing a startup. The tool collects structured, well-tagged data that is not available in the public domain and power the first algorithms that can predict startup success. The company envisages three exit options, namely launching an IPO, avail buyout offers from big technology entities and avail buyout offers from financial buyers.
days to go:
Expired
investment:
£525,500
Mous is a fashion/tech brand that’s disrupting the $37billion phone accessories category. Mous has had huge exposure already for their latest ergonomic and slim iPhone 6 case that holds and retracts headphones, solving very real shopper problems. The trends of wireless earphones present a real opportunity for Mous in the future.
days to go:
Expired
investment:
£41,580
Network Gaming, with backing from Betfair's founder, is an inventive betting innovation company. They develop unique, responsible sports prediction products, supported by a team experienced in industry giants like FanDuel and Betfair. Their offerings help media and betting firms stand out, driving customer acquisition, while prioritizing responsible gaming and dynamic engagement.
days to go:
Expired
investment:
£250,000
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
Pomelo Pay develops mobile applications for merchants, offering them a way to accept payments from twenty-five different payment methods. Currently, it operates in 4 countries and has helped over 8,000 merchants accept payments without the requirement for expensive specialist hardware. Its vision is to make cashless payments available to all businesses and provide cost-effective, frictionless financial services. It also white-labels its product to banks and PSPs (outside of Europe) which gives it a chance to scale up at an international level. It has successfully launched in three countries in Asia and has signed up over 100 merchants since March 2019. Now, with the proceeds, it is focusing on relaunching in the UK and growing its merchant base.
days to go:
Expired
investment:
£500,000
Improving the railway construction industry by collecting data to reduce inefficiencies and overspending. Rail Diary is a B2B SaaS product that is designed to analyse information on infrastructure projects to improve particular elements that plague the industry. These include the delivery, commercialisation and the health and safety of projects.
Rail Diary allows developers to monitor ongoing costs, forecast for the future and reduce the number of claims made. Rail Diary will generate revenue via a monthly subscription model ranging from £45 to £150, plus project fees.
days to go:
Expired
investment:
£50,544
SkiBro is a leading business-to-customer (B2B) Software as a Service (SaaS) platform that aspires to become a contender in the €2 billion ski lessons market. The platform has onboarded 8,000 ski schools and 150,000 ski instructors to date. SkiBro's marketplace encompasses 350 resorts in 7 countries across Europe and North America, with over 6,000 ski instruction products. SkiBro intends to expand into ski hire. The platform has 350 independent ski instructors (250 last year) and 400+ ski schools, with notable ones including ESF La Plagne, ESF Courchevel, Evolution2 (France), Skischule Alberg (Austria), and Ski and Snowboard School Courmayeur (Italy). The company claims that despite COVID-19 hampering business in March 2020, the platform hosted 8.467 lesson bookings worth €1.35 million, recording a 500% YoY growth with an average booking value of €453. SkiBro is seeking £1.5 million of equity funding to accelerate company growth and deliver profitability in 2023-2024.
days to go:
Expired
investment:
£749,825
Carrying a colossal 1.1 billion passengers a year, the Underground is a global hub of young Londoners crossing paths on a daily basis. And with 47% of them identifying a stranger they find attractive at least once a week, there remains no contemporary means of reaching out to them.
Spark launched at the beginning of March, and with minimal finance, has so far generated over 10,000 downloads. Averaging 300 new users a day.
days to go:
Expired
investment:
£44,996
TradeZapp is a collaboration of experienced tradespeople and leading technology professionals. The company has a close understanding of its target market and the challenges associated with it like connecting consumers with professional trade services for latest work opportunities. TradeZapp provides the market with on-demand home services in the UK as well as all over the world. The company's V1 pilot app is available for download on both Android and iOS. TradeZapp also has a fully developed: V2 working prototype that is ready for cross-platform development. It might have the opportunity to raise series A funding and grow into other key international markets.
days to go:
Expired
investment:
Withheld
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform.
days to go:
Expired
investment:
£1,040,000
